Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 34 pseudogene (RNU7-34P) is a human non-coding RNA gene classified as a pseudogene and does not produce a functional RNA or protein product[1][5][9]. It is related by sequence to U7 small nuclear RNA, which is an essential component of the U7 small nuclear ribonucleoprotein (snRNP) complex involved in histone pre-mRNA processing[4], but pseudogenes such as RNU7-34P lack function due to sequence changes or truncation and are not known to participate in any biological processes or disease mechanisms[7]. RNU7-34P is not considered a therapeutic target or biomarker and has no established role in pharmacology, disease, or biology beyond being a processed pseudogene[1][7][9].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 34 pseudogene (RNU7-34P).